WegovySouth San Francisco, CA

Wegovy in South San Francisco, CA

Accessing GLP-1 treatment in South San Francisco, California has traditionally meant longer waits than mainland patients face. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any South San Francisco address at $199/month. Compounded Semaglutide is not FDA-approved.

FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · South San Francisco is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Wegovy in South San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in South San Francisco from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Wegovy® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2021 for Chronic weight management. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for South San Francisco residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In South San Francisco, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

The most common side effects of Semaglutide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Semaglutide program starts at $199/month and covers your medication, provider consultations, and free delivery to South San Francisco. No insurance claims, no prior authorizations, and no surprise bills. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Wegovy® is a Injectable pen manufactured by Novo Nordisk, FDA-approved since 2021 for Chronic weight management. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Wegovy® is taken Once weekly. Weight Method does not sell Wegovy®; we are a separate program that prescribes compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $199/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your South San Francisco address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Start Your Treatment

Consult with a licensed provider in California and start Wegovy from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in South San Francisco

Ozempic in South San FranciscoMounjaro in South San FranciscoZepbound in South San FranciscoRybelsus in South San FranciscoSemaglutide in South San Francisco

Nearby Cities

Wegovy in San Bruno, CAWegovy in Pacifica, CAWegovy in Daly City, CAWegovy in Millbrae, CA

See More

All About WegovySemaglutide in South San FranciscoClinics in South San Francisco